Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.

Détails

Ressource 1Télécharger: smw.2015.14151.pdf (1409.77 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_E9E2CA8F61B5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.
Périodique
Swiss Medical Weekly
Auteur(s)
Babaker M., Breault S., Beigelman C., Lazor R., Aebischer N., Qanadli S.D.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
145
Pages
w14151
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
PRINCIPLES: To assess the efficiency and complication rates of vaso-occlusion of pulmonary arteriovenous malformations (PAVMs) in Rendu-Osler-Weber disease (hereditary haemorrhagic telangectasia; HHT).
METHODS: Seventy-two patients were investigated in our institution for HHT between March 2000 and November 2011. Sixteen presented PAVMs (22.2%), and 11 (68.8%) were treated with vaso-occlusion for a total of 18 procedures. Procedures included coils, plugs and combined approaches. Immediate success and recurrence rate, complication were recorded, as well as persistent and new PAVMs during clinical and computed tomography (CT) follow-up.
RESULTS: Eighteen procedures were performed and a total of 37 PAVMs were treated, 19 with coils, 16 with plugs and 2 with combined treatment. Mean CT follow-up time was 41 months (1‒164). No major complication was observed. One distal translocation was treated during the same intervention. Two PAVMs persisted after treatment (5.7%), both treated by means of plug embolisation. One new PAVM was observed during follow-up CT. PAVMs with an afferent artery of less than 3mm or asymptomatic PAVMs were not treated.
CONCLUSION: Recent studies have demonstrated that vaso-occlusion has become the gold standard treatment for PAVM. This study is in accordance with previous results and shows a minimal complication rate and little recurrence, whether by coils, plugs, or combined treatments.
Mots-clé
Adult, Aged, Aged, 80 and over, Arteriovenous Fistula/etiology, Arteriovenous Fistula/therapy, Embolization, Therapeutic/methods, Female, Humans, Male, Middle Aged, Pulmonary Artery/abnormalities, Pulmonary Veins/abnormalities, Telangiectasia, Hereditary Hemorrhagic/complications
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/10/2015 15:08
Dernière modification de la notice
20/08/2019 17:12
Données d'usage